Comments
Loading...

ANI Pharmaceuticals Analyst Ratings

ANIPNASDAQ
Logo brought to you by Benzinga Data
$62.49
1.041.68%
At close: -
$62.49
0.000.00%
After Hours: Mar 14, 4:00 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$94.00
Lowest Price Target1
$62.00
Consensus Price Target1
$79.75

ANI Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:ANIP | Benzinga

ANI Pharmaceuticals Inc has a consensus price target of $79.75 based on the ratings of 9 analysts. The high is $94 issued by HC Wainwright & Co. on March 3, 2025. The low is $62 issued by Truist Securities on October 22, 2024. The 3 most-recent analyst ratings were released by Jefferies, JP Morgan, and Guggenheim on March 14, 2025, March 12, 2025, and March 5, 2025, respectively. With an average price target of $83.67 between Jefferies, JP Morgan, and Guggenheim, there's an implied 33.89% upside for ANI Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Sep 24
1
Oct 24
1
Nov 24
1
Dec 24
4
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Jefferies
JP Morgan
Guggenheim
HC Wainwright & Co.
Leerink Partners

1calculated from analyst ratings

Analyst Ratings for ANI Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for ANI Pharmaceuticals (ANIP) stock?

A

The latest price target for ANI Pharmaceuticals (NASDAQ:ANIP) was reported by Jefferies on March 14, 2025. The analyst firm set a price target for $80.00 expecting ANIP to rise to within 12 months (a possible 28.02% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for ANI Pharmaceuticals (ANIP)?

A

The latest analyst rating for ANI Pharmaceuticals (NASDAQ:ANIP) was provided by Jefferies, and ANI Pharmaceuticals initiated their buy rating.

Q

When was the last upgrade for ANI Pharmaceuticals (ANIP)?

A

There is no last upgrade for ANI Pharmaceuticals

Q

When was the last downgrade for ANI Pharmaceuticals (ANIP)?

A

The last downgrade for ANI Pharmaceuticals Inc happened on September 11, 2024 when Truist Securities changed their price target from $80 to $60 for ANI Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for ANI Pharmaceuticals (ANIP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ANI Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ANI Pharmaceuticals was filed on March 14, 2025 so you should expect the next rating to be made available sometime around March 14, 2026.

Q

Is the Analyst Rating ANI Pharmaceuticals (ANIP) correct?

A

While ratings are subjective and will change, the latest ANI Pharmaceuticals (ANIP) rating was a initiated with a price target of $0.00 to $80.00. The current price ANI Pharmaceuticals (ANIP) is trading at is $62.49, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch